News Sanofi recalls popular heartburn drug Zantac as FDA investigates probable carcinogen October 18, 2019 Ken Alltucker, USA TODAY Comments Off on Sanofi recalls popular heartburn drug Zantac as FDA investigates probable carcinogen Sanofi said it will voluntarily recall Zantac as the drugmaker and FDA investigate the source of NDMA, a probable carcinogen.